Dundee and Boehringer Ingelheim scientists degrade undruggable cancer targets SMARCA2/4
Read the article Open Access as SharedIt version Fantastic job Will, Manfred and team! Researchers can now access the SMARCA2/4 degrader ACBI1 for their own research – order the molecule completely free of charge from OpnMe. Related Links UoD PR: Boehringer…